Simocyclinone D8, an Inhibitor of DNA Gyrase with a Novel Mode of Action

AUTOR(ES)

Flatman, Ruth H.

FONTE

American Society for Microbiology

RESUMO

We have characterized the interaction of a new class of antibiotics, simocyclinones, with bacterial DNA gyrase. Even though their structures include an aminocoumarin moiety, a key feature of novobiocin, coumermycin A1, and clorobiocin, which also target gyrase, simocyclinones behave strikingly differently from these compounds. Simocyclinone D8 is a potent inhibitor of gyrase supercoiling, with a 50% inhibitory concentration lower than that of novobiocin. However, it does not competitively inhibit the DNA-independent ATPase reaction of GyrB, which is characteristic of other aminocoumarins. Simocyclinone D8 also inhibits DNA relaxation by gyrase but does not stimulate cleavage complex formation, unlike quinolones, the other major class of gyrase inhibitors; instead, it abrogates both Ca2+- and quinolone-induced cleavage complex formation. Binding studies suggest that simocyclinone D8 interacts with the N-terminal domain of GyrA. Taken together, our results demonstrate that simocyclinones inhibit an early step of the gyrase catalytic cycle by preventing binding of the enzyme to DNA. This is a novel mechanism for a gyrase inhibitor and presents new possibilities for antibacterial drug development.

Documentos Relacionados

• Mode of action of GR122222X, a novel inhibitor of bacterial DNA gyrase.
• Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
• In vitro evaluation of ABT-719, a novel DNA gyrase inhibitor.
• Mode of Action of Albocycline, an Inhibitor of Nicotinate Biosynthesis
• Mode of Action of Melinacidin, an Inhibitor of Nicotinic Acid Biosynthesis